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Abstract
Background: Insulin deficiency is the prime basis of all diabetic manifestations and agents that can bring about
insulin secretion would be of pivotal significance for cure of diabetes. To test this hypothesis, we carried out
bioactivity guided fractionation of Oreocnide integrifolia (Urticaceae); a folklore plant consumed for ameliorating
diabetic symptoms using experimental models.
Methods: We carried out bioassay guided fractionation using RINmF and C2C12 cell line for glucose stimulated
insulin secretion (GSIS) and glucose uptake potential of fractions. Further, the bioactive fraction was challenged for
its GSIS in cultured mouse islets with basal (4.5 mM) and stimulated (16.7 mM) levels of glucose concentrations.
The Flavonoid rich fraction (FRF) was exposed to 2 mM streptozotocin stress and the anti-ROS/RNS potential was
evaluated. Additionally, the bioactive fraction was assessed for its antidiabetic and anti-apoptotic property in-vivo
using multidose streptozotocin induced diabetes in BALB/c mice.
Results: The results suggested FRF to be the most active fraction as assessed by GSIS in RINm5F cells and its
ability for glucose uptake in C2C12 cells. FRF displayed significant potential in terms of increasing intracellular
calcium and cAMP levels even in presence of a phosphodiesterase inhibitor, IBMX in cultured pancreatic islets. FRF
depicted a dose-dependent reversal of all the cytotoxic manifestations except peroxynitrite and NO formation
when subjected in-vitro along with STZ. Further scrutinization of FRF for its in-vivo antidiabetic property
demonstrated improved glycemic indices and decreased pancreatic b-cell apoptosis.
Conclusions: Overall, the flavonoid mixture has shown to have significant insulin secretogogue, insulinomimetic
and cytoprotective effects and can be evaluated for clinical trials as a therapeutant in the management of diabetic
manifestations.
Background
Despite being one of the oldest diseases, a composite
therapy has eluded the world to date for diabetes melli-
tus and, WHO has declared it as a chronic disease. It is
proving to be a serious life threatening heterogeneous
metabolic disorder affecting carbohydrate, lipid and pro-
tein metabolisms and afflicting nearly an estimated 191
million people in 2000 and expected to affect an esti-
mated 306 million by 2030 [1,2]. The metabolic
derangements characteristic of diabetes in general is pri-
marily a consequence of relative insufficiency of insulin
secretion and/or insulin action [3]. Escalating frequency
of the disorder is likely to affect developing countries
due to expensive and inadequate treatments coupled
w i t ht h el a c ko fe f f e c t i v ea n daffordable interventions
[4,5].
Since the causes of diabetes are multifactorial and
fraught with life threatening consequences; the disorder
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peutic intervention that is more potent and sans side
effects. It is in this context that the World Health Orga-
nization (WHO) has encouraged and recommended the
use of herbs as an alternative therapy for diabetes [6]
and, though a wide range of medicinal plants are in use
world over, many of them are however with no valid
scientific sanctity. The suggested need for alternative
therapy has pinned renewed attention on the search for
plant based anti-diabetic agents, also favored due to
their easy availability, effectiveness, affordability and
probable low ill effects [7]. Apparently, a systematic
scientific scrutiny of the anti-diabetic potentials of these
plants has become a matter of utmost importance to
justify their application in ethnomedicine. Due to their
rich diversity and complement of active phytochemicals
and secondary metabolites, plants from ancient human
civilization have been used as medicament for very
many ailments [8-11]. Plants/herbs constitute the main
stay of health care system in rural areas due to limited
access to modern health facilities.
Indian rural and folklore ethnomedical practices
involve usage of many relatively unknown medicinal
plants with scientifically non-characterized pharmacolo-
gical activities. One such folklore plant is “Oreocnide
integrifolia“ popular in northeastern parts of India, espe-
cially Manipur, which is consumed as an anti-diabetic
therapeutant by Garo, Khasi and Jayantia tribes and by
local populace. In this context, we initiated a scientific
evaluation of this botanical on various animal models of
diabetes [12-14].
Since the primary defects of diabetes centre around b-
cell dysfunction, insulin secretion and insulin action, we
carried out bioactivity guided assays to identify bioactive
fraction using RINm5F and C2C12 cell line as experi-
mental in-vitro models for their insulin secretion ability
in presence of glucose and their glucose uptake ability
in presence of insulin respectively. Flavonoid rich frac-
tion (FRF) exhibited maximal potential in terms of these
bioactivities. Further, streptozotocin exposed islets were
challenged with FRF to assess glucose stimulated insulin
secretion and its cytoprotective potential. Additionally,
the dose-dependent anti-diabetic potential of the active
fraction (FRF) was also tested in-vivo using multidose
streptozotocin diabetic mice.
Methods
Extraction and fractionation
Fresh green leaves were dried and powdered in a grin-
der. The powder (100 g) mixed with 500 mL of n-hex-
ane in round bottomed flask was filtered after 48 hrs
and the hexane concentrated using a rota evaporator
(Buchi, Germany) to obtain hexane fraction. The
defatted powder dried free of hexane was subjected to
stepwise sequential solvent extraction with Chloroform,
Ethyl acetate, Methanol and n-Butanol in a soxhlet
apparatus.
Flavonoid rich fraction
Briefly, One hundred g of air-dried leaves were ground
to fine powder and soaked in 70% ethanol for 24 h with
continuous stirring. The soaked mixture was filtered
using Whatmann No. 1 filter paper and the pellet dis-
carded after centrifugation of the filtrate at 10,000 rpm
at room temperature (25°C). The supernatant was con-
centrated in vacuo by means of a rotavapor and then
dissolved in as little water as possible and washed three
times with chloroform. The resultant residual layer after
extraction three times with ethyl acetate and subjected
to concentration in vacuo served as the flavonoid rich
fraction (FRF).
In vitro and in vivo bioactivity assays
Mouse Islet Isolation
Islet isolation was as per the methods of [15] and [16].
Briefly, Splenic lobe of pancreas was removed under
sterile conditions from groups of three BALB/c mice
killed by cervical dislocation without ductal injection
and distention. Briefly, the pancreas was cut into small
pieces/chopped finely ~1 mm
2 and was subjected to
enzymatic digestion for 10-12 min by vigorous mechani-
cal shaking in a water bath maintained at 37°C. The dis-
sociation medium consisted of Dulbecco’s Modified
Minimum Essential Medium (DMEM) supplemented
with Collagenase type V (1 mg/mL; Sigma, St. Louis,
MO), and 2% BSA fraction V (Hi-Media Labs, Mumbai).
The digested tissue was then centrifuged at 1500 g for
10 min, washed twice in PBS (pH: 7.4) and seeded in
culture flasks (25 cm
2; Nunc, Denmark) containing
RPMI-1640 (Hyclone, USA) supplemented with 10% (v/
v) FBS (Hi-Media, India), 100 U/mL penicillin and 100
U/mL streptomycin under 95% O2 and 5% CO2 atmo-
sphere at 37°C (Thermo, USA) in air. Under these cul-
ture conditions, most of the acinar cells degenerate
within 48 hrs leaving behind islets. After 48 hrs of incu-
bation, islets handpicked from exocrine pancreas using a
binocular stereomicroscope were quantified using auto-
mated Microsoft Excel sheet and number of islet equiva-
lents recorded based on their size. For further
purification, islets (freed of acinar cells) were isolated
using density gradient Ficoll reagent- Type 400 (Hi-
Media Labs, Mumbai) present in 20-11% interface. The
islets specificity was assessed using dithizone staining
(Hi-Media, Mumbai, Maharashtra, India) while islet via-
bility was performed using Trypan blue staining.
Cell lines
RINm5F and C2C12 cell lines procured from National
Centre for Cell Sciences, Pune, India served as the
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tained in RPMI 1640 supplemented with 10% FCS, 100
IU penicillin/mL and 100 μg streptomycin/mL and incu-
b a t e da t3 7 ° Cu n d e rah u m i d i f i e d5 %C O 2 atmosphere.
The cells allowed to grow in 25 cm
2 tissue culture flasks
until confluence were then sub-cultured for experimen-
tation. RINm5F cells were subjected to glucose stimu-
lated insulin secretion and cultured in either basal (4.5
mM) or stimulated (16.7 mM) glucose concentrations.
Insulin secretion assays were quantified using Mouse/
Rat Insulin ELISA kit (Mercodia, Sweden).
Glucose induced insulin secretion assay (GSIS)
Isolated islets were cultured at 37°C in a humidified
atmosphere of 5% CO2 in air in RPMI-1640 medium
containing 10% FBS and antibiotics. Islets were seeded
at a concentration of 100 or 50 islets per well in 24-well
plates (Falcon, NJ) and allowed to attach overnight prior
to acute tests. Wells were washed three times with
Krebs-Ringer bicarbonate buffer (KRB; 115 mM NaCl,
4.7 mM KCl; 1.3 mM CaCl2,1 . 2m MK H 2PO4,1 . 2m M
MgSO4,2 4m MN a H C O 3, 10 mM HEPES, 1 g/L BSA,
1.1 mM glucose; pH 7.4) and pre-incubated for 1 hr at
37°C. Unless otherwise stated, wells were then incubated
f o r1hi n1m LK R Bw i t h4 . 5m Mo r1 6 . 7m Mg l u c o s e
and OI extract/FRF (10, 50, 100 or 250 μg/mL). Aliquots
were removed from each well, centrifuged (2000 rpm for
5 min, at 4°C), and assayed for insulin with mouse insu-
lin ELISA kit and protein concentration was determined.
2NBDG glucose uptake
Glucose uptake studies was carried out using fluorescent
probe 2-[N-(7-Nitrobenz-2-oxa-1, 3-diazol-4-yl) amino]-
2-deoxy-d-glucose (2NBDG) [17]. Briefly, Dulbecco’s
Modified Eagle Medium (DMEM) supplemented with
15% Fetal Calf Serum and antibiotics (Penicillin 100 IU/
mL and Streptomycin 100 μg/mL) in 5% CO2 at 37°C
served as the medium for maintenance of C2C12 skele-
tal muscle cell line. After attainment of ~70% con-
fluency, cells switched to 2% horse serum for 3 days
served the purpose of differentiation. The differentiated
myotubes were seeded in 96 well fluorescence plates
with BSA (1 mg/mL) and 80 μM fluorescent analogue,
2NBDG [Invitrogen, Carlsbad, CA] in presence of differ-
ent concentrations of various fractions or FRF for 60
min. For stimulation experiments, 100 nM insulin was
added along with fractions or FRF. The cells were
washed three times to remove free 2NBDG and, plates
were read at excitation wavelength of 485 nm and an
emission wavelength of 535 nm using Fluorescent micro
plate readers (Molecular Devices, Sunnyvale, USA).
Dose optimization (islet studies)
Optimization studies for different concentrations/doses
o fS T Z( 1m M ,2m Ma n d5m M )a n df o rd u r a t i o no f
STZ exposure (2 hr, 6 hr, 8 hr and 12 hr) were carried
out. Different concentrations of FRF (10, 50, 100 and
250 μg/mL) were tested for STZ insult/stress experi-
ments. STZ (2 mM) with an exposure time of 8 hrs was
characterized as the best-optimized schedule for experi-
mental studies. Experimental groups consisted of control
and STZ treated islets, pre-treated with FRF for a period
of 24 hrs.
Intracellular Calcium levels
The intracellular calcium concentration, [Ca
2+]i, was
measured using fura-2AM (Molecular Probes, Invitro-
gen, USA). Fura-2AM crosses cell membranes and once
inside the cell, the acetoxymethyl groups removed by
cellular esterases generate fura-2, the fluorescent cal-
cium indicator. Islets were incubated in calcium free
HBSS with 5 μMf u r a - 2 A Ma t3 7 ° Cf o r3 0m i ni ns h a k -
ing water bath. After washing (2×) with calcium free
HBSS, islets were suspended in complete HBSS and
treated with various concentrations of FRF for 60 min
in a shaking water bath. Fluorescence was measured in
a spectrofluorimeter (Hitachi 7000, Japan) at an emis-
sion wavelength of 500 nm for dual excitation wave-
length at 340 and 380 nm. The [Ca
2+]i was expressed as
nmole/50 islet equivalents.
cAMP estimation
For cAMP measurements, islets cultured in 24-well
plates were exposed to 11.1 mM glucose for 60 min in
presence of the phosphodiesterase inhibitor 3-isobutyl-
1-methylxanthine (1 mM) [IBMX] and various concen-
trations of FRF. At the end of incubation, islets were
lysed following the manufacturer’s instructions, and
cAMP quantification was performed using a cAMP
direct immunoassay kit (Abcam, USA) and normalized
to protein concentrations. Results were expressed as
fmol/μg protein.
MTT assay
The viability of cultured islets was determined by assay-
ing the reduction of 3-(4, 5-dimethylthiazol-2-yl) - 2, 5-
diphenyltetrazolium bromide (MTT) to formazan. Briefly,
islets were seeded in 24-well microtiter plates (50 islets
per well) and left overnight to adhere before being
exposed to different concentrations of STZ and FRF. In
each experiment, different concentrations of FRF (10, 50,
100, 250 μg/mL) along with 2 mM STZ were tested in
three separate wells and the cytotoxicity assessed from at
least three different experiments. After exposure to STZ
and FRF, incubation of the wells was carried out in dark
at 37°C for 4 h after addition of 50 μlo f5m MM T T
solution. Subsequently, formazan crystals were dissolved
in 200 μl of DMSO after the removal of MTT and the
absorbance measured at 570 nm using a Microplate
Reader (Biotek Instruments, USA).
ROS estimation
The intracellular formation of reactive oxygen species
(ROS) was measured using 2’,7 ’-dichlorodihydrofluorescin
diacetate (DCFH-DA) (Fluka Chemicals, USA). The
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cell and is cleaved by intracellular esterases, resulting in
the formation of 2’,7 ’-dichlorodihydrofluorescin (DCFH),
the oxidation of which (due to oxidative stress) generates
the fluorescent compound dichlorofluorescein. Thus, the
DCF fluorescence represents the rate and quantity of ROS
produced. Fifty islets from all treatment groups, incubated
in fresh media with 10 μM DCFH-DA at 37°C for 30 min,
was washed twice with PBS and the fluorescence mea-
sured using a fluorimeter (Hitachi 7000, Japan) with exci-
tation at 495 nm and emission at 538 nm. All values were
corrected by subtracting auto fluorescence for respective
wells and the results expressed as relative fluorescence
units/50 islet equivalents
Peroxynitrite estimation
Concentration of peroxynitrite from respective treatment
groups was estimated by incubating 50 islets with 10 μM
dihydrorhodamine 123 (DHR123) for 30 min. Fluores-
cence was measured using excitation at 500 nm and
emission at 530 nm (Hitachi 7000 Spectrofluorimeter).
Auto-fluorescence deducted from total fluorescent count
yielded corrected fluorescent intensity, expressed as rela-
tive fluorescence units/50 islets equivalents.
Nitric oxide estimation
For estimation of the concentration of Nitric oxide from
respective treatment groups, 50 islets were incubated
with the fluorescent probe DAF-FM (1 μM) for 30 min
and then washed with PBS. Fluorescence was measured
using excitation at 485 nm and emission at 520 nm
(Hitachi 7000 Spectrofluorimeter). Auto-fluorescence
was deducted from total fluorescent count for corrected
fluorescent intensity and was expressed as relative fluor-
escence units/50 islets equivalents.
Evaluation of Mitochondrial Membrane Potential (Δψm)
Mitochondria are vulnerable targets for various toxicants
because of their important role in maintaining cellular
integrity and functions. Functional alterations occur in
mitochondria due to changes in mitochondrial mem-
brane potential. Disruption of the mitochondrial mem-
brane potential (i.e. depolarization) is one of the earliest
indicators of cellular disturbance. Fifty islets were loaded
with a cationic fluorescent dye Rh-123. From the respec-
tive treatment groups, islets changed to serum free
media containing Rh-123 (10 μM) were incubated for 30
min at 37°C. Results were expressed as relative fluores-
cent units/50 islet equivalents.
LPO estimation
Lipid peroxidation was monitored in terms of malonal-
dehydes formed [18]. Briefly, islets were suspended in
200 μl of 1.15% KCl. To this suspension were added
0.8% TBA, 1% SDS and 20% acetic acid. The reaction
mixture was kept at 90°C for 45 min and immediately
cooled on ice. The pink colour representative of thiobar-
bituric acid reactive substances was measured at 532 nm
and protein concentration determined. The values were
expressed as nmoles of MDA formed/mg protein.
Multiple dose Streptozotocin model
For induction of diabetes,B A L B / cm i c e( ~ 3 0g )w e r e
fasted overnight and injected with 50 mg/kg body weight
of streptozotocin dissolved in sodium citrate buffer (pH
4.5) intraperitoneally for five consecutive days to delete
b-cells. Mice were provided 10% sucrose solution to pre-
vent sudden hypoglycemia. Mice that exhibited frank dia-
betes (blood glucose levels > 220 mg/dl after 2 weeks)
were considered for the experimental studies. Mice were
injected flavonoid rich fraction (FRF) for a period of 28
days at a dose 100, 250 and 500 mg/kg of body weight
once daily at 1000 hrs. Mice were fasted overnight prior
sacrifice. All experiments were carried out according to
the guidelines of the Committee for the Purpose of Con-
trol and Supervision of Experiments on Animals, India
and approved by the Animal Ethical Committee of
Department of Zoology, The M.S. University of Baroda,
Vadodara (Approval No.827/ac/04/CPCSEA).
Glucose and insulin
Blood glucose was estimated using Glucometer (Roche
Diagnostics, USA) and insulin levels were estimated
using mouse insulin ELISA (Mercodia, Sweden) with an
intra-assay of coefficient variance of > 5%.
TUNEL/Insulin immunostaining & confocal microscopy
The Terminal dUTP transferase mediated Nick End
Labeling (TUNEL) assay was performed to assess the in
situ DNA fragmentation in paraffin embedded pancreas
sections according to the manufacturer’si n s t r u c t i o n s
using APO-BrdU™ TUNEL Assay Kit (Invitrogen,
USA). Briefly, animals were sacrificed after treatment
period and the excised pancreas preserved in 4% paraf-
ormaldehyde. Sections were deparaffinised in xylene,
downgraded in alcohol grades (100, 95, 85, 70 and
50%), washed with PBS and fixed in fresh 4% parafor-
maldehyde (PFD) followed by Proteinase-K treatment.
Slides were again fixed in 4% PFD and DNA labeling
solution added. Guinea pig anti-insulin (1:100, Abcam,
USA) was used to probe insulin. Nuclear staining was
achieved by adding DAPI/Rnase-A. Anti-Fade solution
(Vectamount, Vector Labs, USA) was used as mountant.
The slides were visualized by Laser Scanning Confocal
Microscope (LSM 510META, ZEISS, Germany). Apop-
totic cells exhibited strong nuclear green fluorescence.
Optical slices were taken at ~ 0.8 μm. Laser gains, pin-
hole setting, and magnification was set identical across
samples.
Statistics
Statistical evaluation of the data was done by one way
ANOVA followed by Bonferroni’s Multiple comparison
test. The results are expressed as mean ± S.E using
Graph Pad Prism version 5.0 for Windows, Graph Pad
Software, San Diego, California USA.
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GSIS of various solvent extracts from RINm5F cell line
Except for the ethyl acetate and methanol fractions,
which showed a dose-dependent increase in insulin
release, none of the other fractions showed any notice-
able effect on insulin release under basal (4.5 mM glu-
cose) glucose concentration (Figure 1). Under higher
concentration of ambient glucose, both ethyl acetate (2-
3 fold) and methanol (3-4 fold) fractions showed signifi-
cant dose-dependent increment in insulin release. In
addition, both chloroform and butanol fractions
depicted some degree (1.5 fold) of increment in insulin
release, especially with the higher dose.
Promotion of 2NBDG glucose uptake by various solvent
extracts in C2C12 cells
Basal glucose uptake was significantly less in presence of
all solvent fractions compared to insulin (Figure 2). How-
ever, ethyl acetate and methanol fractions showed dose-
dependent increment in glucose uptake, which was sig-
nificantly greater than other fractions tested. However,
higher concentration of n-butanol fraction showed maxi-
mal glucose uptake compared to both ethyl acetate and
methanol fractions. Even though all fractions showed
dose-dependent increment in glucose uptake in presence
of insulin, it was still lesser compared to insulin alone,
except for the higher dose of ethyl acetate fraction and
both doses of methanol fraction, which showed maximal
glucose uptake more than that shown by insulin.
GSIS from RINm5F cells by FRF fraction
Under both basal (4.5 mM) and higher (16.7 mM) glu-
cose ambient concentrations, the FRF fraction depicted
a dose- dependent increment in insulin secretion with
the highest dose showing almost doubled insulin secre-
tion (Figure 3A).
FRF stimulated 2NBDG glucose uptake by C2C12 cells
The FRF fraction depicted a dose-dependent 5-15 fold
increase in glucose uptake even in the absence of insu-
lin. The insulin induced glucose uptake was further sti-
mulated 2-5 fold in a dose-dependent manner by the
FRF fraction (Figure 3B).
GSIS by FRF from isolated mouse islets
The FRF induced significant dose-dependent increment in
insulin secretion from mouse islets under both basal (4.5
mM) and stimulated (16.7 mM) glucose concentrations
Glucose induced insulin secretion in RINm5F cell line
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Figure 1 Effect of different fractions of Oreocnide integrifolia on glucose stimulated insulin secretion. RINm5F cells were either cultured
in basal (4.5 mM) or stimulated (16.7 mM) glucose concentrations in presence of fractions. Insulin secretion was quantified using Rat Insulin
ELISA kit. Values are expressed as ± SEM in triplicates where ￿ = p < 0.01, ■ = p < 0.001, ♦ = p < 0.0001: when control was compared with rest
of the groups; a = p < 0.01, b = p < 0.01, δ = p < 0.01: when 4.5 mM glucose group was compared to rest of the groups and ➊ = p < 0.01, ➋ =
p < 0.01, ➌ = p < 0.01: when 16.7 mM glucose group was compared to rest of the groups.
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Page 5 of 13(Figure 3C). The increment in insulin release under glu-
cose challenge was significantly greater than in the basal
state. The highest dose of FRF showed near 45% increase
in GSIS.
Effect of FRF on glucose induced increase in cAMP and
Ca
++ levels in islets
There was no increase in intra-islet cAMP (Figure 3D)
or Ca
++ (Figure 4A) on exposure to any of the doses of
FRF under basal ambient glucose level. However, under
stimulating concentration of glucose, a dose-dependent
increment by FRF in intra islet cAMP and Ca
++ levels
could be noticed. Further, this dose-dependent effect of
FRF on cAMP and Ca
++ levels could be discerned in a
medium containing less stimulating concentration (11.1
mM) of glucose and the PDE inhibitor IBMX.
In-vitro assessment of the effect of FRF on streptozotocin
induced islet viability and oxidative stress
All oxidative stress parameters, MTT (Figure 4B), DCF
(Figure 4C), Peroxynitrite (Figure 5A), NO (Figure 5B),
R h1 2 3( F i g u r e5 C ) ,a n dL P O( F i g u r e5 D ) ,w e r ea l ls i g -
nificantly elevated in presence of streptozotocin. FRF
protected the islets against STZ induced oxidative stress
in a dose-dependent manner with the highest dose
affording near total protection. Streptozotocin signifi-
cantly reduced cell viability, which was protected against
by the co-presence of FRF in a dose-dependent mode.
Assessment of the anti-diabetic potential of FRF in
multidose STZ mice
Blood glucose and insulin level
At the end of 28 day period streptozotocin diabetic mice
displayed significant hyperglycemia and hypoinsuline-
mia. FRF treated mice showed significant increase in
plasma insulin and concomitant decrease in glucose in a
dose-dependent manner (Table 1).
Histopathological observations
The pancreatic islets of streptozotocin-administered mice
depicted b-cell loss and wider intracellular spaces due to
b-cell toxicity of STZ (Figure 6A-E). FRF supplementa-
tion showed recovery of the structural integrity of islets
2NBDG Glucose Uptake in C2C12 Cells (Fractions)
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Figure 2 Effect of different fractions of Oreocnide integrifolia on glucose uptake in C2C12 cells. Differentiated C2C12 cells were incubated
with or without 100 nM of insulin along with various fractions. Glucose uptake was measured by using 2NBDG fluorescent probe. Values are
expressed as ± SEM in triplicates where ￿ = p < 0.01, ■ = p < 0.001, ♦ = p < 0.0001 when control group was compared with rest of the groups
and a = p < 0.01, b = p < 0.01, δ = p < 0.01 when insulin treated group was compared to rest of the groups.
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Figure 3 (A). Represents effect of flavonoidal fraction on glucose stimulated insulin secretion in RINm5F cells. RINm5F cells were either
cultured in basal (4.5 mM) or stimulated (16.7 mM) glucose concentrations in presence of fractions. Insulin secretion was quantified using Rat
Insulin ELISA kit. Values are expressed as ± SEM in triplicates where ￿ = p < 0.01, ■ = p < 0.001, ♦ = p < 0.0001 when 4.5 mM glucose group
was compared to FRF 10, 50, 100, 250 and a = p < 0.01, b = p < 0.01, δ = p < 0.01 when 16.7 mM glucose group was compared to FRF 10, 50,
100, 250 group.(B) Represents effect of flavonoid fraction on glucose uptake in C2C12 cells. Differentiated C2C12 cells were incubated with or
without 100 nM of insulin along with flavonoidal fraction. Glucose uptake was measured by using 2NBDG fluorescent probe. Values are
expressed as ± SEM in triplicates where ￿ = p < 0.01, ■ = p < 0.001, ♦ = p < 0.0001 when control was compared with rest of the groups and a
= p < 0.01, b = p < 0.01, δ = p < 0.01: Insulin was compared to rest of the groups. (C) Represents effect of flavonoidal fraction on insulin
secretion on isolated mouse islets. Islets were either cultured in basal (4.5 mM) or stimulated (16.7 mM) glucose concentrations in presence of
flavonoidal fraction. Insulin secretion was quantified using Mouse Insulin ELISA kit. Values are expressed as ± SEM in triplicates where ￿ =p<
0.01, ■ = p < 0.001, ♦ = p < 0.0001 when 4.5 mM glucose group was compared to FRF 10, 50, 100, 250 groups and a = p < 0.01, b = p < 0.01,
δ = p < 0.01 when 16.7 mM glucose group was compared to FRF 10, 50, 100, 250. (D) Represents effect of flavonoidal fraction on cAMP levels in
mouse islets. Cultured islets were exposed to 11.1 mM for 60 min in the presence of phosphodiesterase inhibitor (1 mM IBMX) along with
flavonoidal fraction. Values are expressed as ± SEM in triplicates where a = p < 0.01, b = p < 0.01, δ = p < 0.01 when 16.7 mM glucose group
was compared to its 10, 50, 100, 250 groups and ➊ = p < 0.01, ➋ = p < 0.01, ➌ = p < 0.01 when 11.1 mM glucose + IBMX group was compared
to its 10, 50, 100, 250 groups.
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Figure 4 (A) Represents effect of flavonoidal fraction on intracellular calcium levels in mouse islets. Intracellular calcium levels were
measured using fluorescent probe fura-2AM. Values are expressed as ± SEM in triplicates where a = p < 0.01, b = p < 0.01, δ = p < 0.01 when
16.7 mM glucose group was compared to its 10, 50, 100, 250 groups and ➊ = p < 0.01, ➋ = p < 0.01, ➌ = p < 0.01 when 11.1 mM glucose +
IBMX group was compared to its 10, 50, 100, 250 groups. (B) Represents effect of flavonoidal fraction on MTT activity in mouse islets. Cultured
islets were exposed to pancreatic b- cell specific toxin, streptozotocin (2 mM) along with flavonoidal fraction at various concentrations and
assessed for cytotoxicity. Values are expressed as ± SEM in triplicates where ￿ = p < 0.01, ■ = p < 0.001, ♦ = p < 0.0001 when control group
was compared with rest of the groups and a = p < 0.01, b = p < 0.01, δ = p < 0.01 where diabetic group was compared to rest of the groups.
(C) Represents effect of flavonoidal fraction on intracellular ROS activity in mouse islets. Intracellular ROS was assessed by fluorescent probe
DCFH-DA. Values are expressed as ± SEM in triplicates where ￿ = p < 0.01, ■ = p < 0.001, ♦ = p < 0.0001 when control group was compared
with rest of the groups and a = p < 0.01, b = p < 0.01, δ = p < 0.01 when diabetic group was compared to rest of the groups.
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Figure 5 (A) Represents effect of flavonoidal fraction on peroxynitrite levels in mouse islets exposed to streptozotocin. Peroxynitrite
levels were quantified by fluorescent probe dihydrorhodamine 123. Values are expressed as ± SEM in triplicates where ￿ = p < 0.01, ■ =p<
0.001, ♦ = p < 0.0001 when control group was compared with rest of the groups and a = p < 0.01, b = p < 0.01, δ = p < 0.01 when diabetic
group was compared to rest of the groups (B) Represents effect of flavonoidal fraction on NO levels in mouse islets exposed to streptozotocin.
Nitric oxide levels were quantified by fluorescent probe DAF-FM. Values are expressed as ± SEM in triplicates where ￿ = p < 0.01, ■ = p < 0.001,
♦ = p < 0.0001 when control group was compared with rest of the groups and a = p < 0.01, b = p < 0.01, δ = p < 0.01 when diabetic group
was compared to rest of the groups (C) Represents effect of flavonoidal fraction on mitochondrial membrane potential (MMP) in mouse islets
exposed to streptozotocin. MMP levels were quantified by fluorescent probe Rhodamine 123. Values are expressed as ± SEM in triplicates where
￿ = p < 0.01, ■ = p < 0.001, ♦ = p < 0.0001 when control group was compared with rest of the groups and a = p < 0.01, b = p < 0.01, δ =p<
0.01 when diabetic group was compared to rest of the groups (D) Represents effect of flavonoidal fraction on lipid peroxidation levels (LPO) in
mouse islets exposed to streptozotocin. Lipid peroxidation was measured by using thiobarbituric acid reagent. Values are expressed as ± SEM in
triplicates where ￿ = p < 0.01, ■ = p < 0.001, ♦ = p < 0.0001 when control group was compared with rest of the groups.
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Page 9 of 13with the pancreas of mice administered highest dose of
FRF depicting near normal islet histoarchitecture.
Immunostaining of pancreas for cellular apoptosis and
insulin localization
The pancreatic islets of STZ treated mice depicted
greater number of TUNEL positive cells and on
quantitative terms a six fold higher percentage of apopto-
tic cells (Figure 6F). Pancreatic islets of STZ treated mice
demonstrated reduced immunoreactivity for insulin
while, the islets of FRF supplemented mice showed
increased insulin immunoreactivity, with 250 μgF R F
treated islets showing strong immunoreactivity (Figure
6G).
Discussion
The various extracts tested for their GSIS from RINm5F
cells clearly show stimulatory effects for only ethanolic
and methanolic extracts under basal glucose concentra-
tion of 4.5 mM. Both these extracts show augmented
GSIS under a stimulating glucose concentration of 16.7
mM glucose with the effect of methanolic extract being
maximal. However, 100 μg/mL butanol fraction also
shows a significant GSIS. Apparently, active phytochem-
ical ingredients with insulin secretogogue properties
seem to be present in alcoholic extracts of OI, suggest-
ing the secretogogues to be polar in nature. The herein
Table 1 Effect of FRF on plasma glucose levels and
insulin titres in normoglycaemic and mSTZ diabetic mice.
Plasma Glucose
(mg/dl)
Plasma insulin
(μIU/ml)
Control 107.67 ± 4.50 22.64 ± 0.75
Diabetic 249.50 ± 8.97
♦ 12.76 ± 1.02
♦
Diabetic + FRF 100 180.76 ± 7.76
♦ δ 13.65 ± 0.76
♦
Diabetic + FRF 250 167.60 ± 8.30
δ 17.86 ± 0.78
￿b
Diabetic + FRF 500 163.98 ± 7.22
δ 17.92 ± 0.72
￿a
All values are expressed as ± SEM (n = 6) where ￿ = p < 0.01, ■ = p < 0.001,
♦ = p < 0.0001 when control group was compared with rest of the groups
and a = p < 0.01, b = p < 0.01, δ = p < 0.01 when diabetic group was
compared with FRF 100, 250, 500 groups
Figure 6 Images represent haemetoxylin and eosin stained pancreas sections of (A) control mice showing intact islet
histoarchitecture, (B) diabetic mice showing islet cell destruction and wider intracellular spaces due to streptozotocin toxicity (C-E)
diabetic animals treated with flavonoidal fraction at 100, 250 and 500 mg/kg bodyweight demonstrating ameliorating effects and
improved islet integrity (Magnification 200×) (F) Quantification of islet cell apoptosis in multiple dose streptozotocin mouse treated
with various concentrations of flavonoidal fraction (G) Images represent confocal optical slices of immunostained pancreas of control,
diabetic and diabetic treated with various concentrations of flavonoidal fraction. Guinea Pig anti insulin (red) and ApoBrdu-dUTP (green)
were used as primary antibodies. DAPI (Blue) was used to visualize nuclei. The slides were visualized by Laser Scanning Confocal Microscope
(LSM 510 META, ZEISS, Germany). Scale bar represents 100 μm).
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Page 10 of 13inferred importance of polar compounds, extractable in
alcoholic solvents, in inducing GSIS finds support in the
recent reports of alcoholic extracts of many plants
showing potential for glucose stimulated insulin secre-
tion from cell lines [19,20]. Some of the active polar
compounds also seem to possess insulinomimetic action
as seen by the ability of alcoholic extracts to promote
glucose uptake in C2C12 Cells. Though these fractions
promoted glucose uptake, it however was relatively les-
s e ri nc o m p a r i s o nt oi n s u l i n .E v e ni np r e s e n c eo fi n s u -
lin, though hexane, ethanolic and butanol fractions
showed enhanced glucose uptake more than that seen
without insulin, was nevertheless still lesser than insulin.
However, methanolic fraction shows a complementary
effect with insulin as, both doses of the extract pro-
moted greater glucose uptake than insulin alone. Appar-
ently, the methanolic extract has the active principle(s)
that promote(s) glucose transport in larger concentra-
tion than in other fractions. The possible reason for the
observed attenuation of glucose uptake (transport) pro-
moting activity of the alcoholic extracts compared to
insulin could be the presence of other interfering sub-
stances in the crude extracts that reduce the potential of
the promoting molecules. Presence of phytochemicals in
alcoholic extracts of other plants, which promote glu-
cose uptake in muscle and adipose cell lines [21-23],
substantiate our observed effect.
Based on our observations of methanolic fraction
being more active in terms of insulin secretogogue and
insulinomimetic functions and, richer flavonoid con-
tent, the isolated FRF was tested for its GSIS and glu-
cose uptake properties. The observations made on
RINm5F and C2C12 cell lines clearly establish the very
potent ability for eliciting insulin release and glucose
uptake. The very high potency of our FRF fraction for
glucoregulation is indicated by the dose-dependent tre-
mendously high insulin secretogogue expression (46%
to 86% under basal glucose concentration and 11% to
37% under stimulating glucose concentration) and
insulinomimetic role in glucose uptake (83% to 240%
in the absence of insulin and 250% to 1450% in pre-
sence of insulin). Relatively, promotion of glucose
uptake seems to be the more significant function of
FRF than, elicitation of insulin release. The observed
markedly high potentials of FRF can be related with
the identified mixture of flavonoids functioning
t o g e t h e r ,e i t h e ri na na d d i t ive or synergistic fashion.
Though there are reports of flavonoids promoting
insulin secretion and glucose uptake under in vitro
conditions [24-26], our FRF seems to exert relatively
more powerful effects. The in vitro effect of FRF on
insulin secretion seen in cell lines stands confirmed by
the observed dose-dependent increment by 23% under
basal and by 44% under stimulated conditions of
insulin release from isolated whole mouse islets.
Clearly, the FRF mixture of OI has appreciable insulin
secretogogue ability and is ideal for treatment of insu-
lin deficiency under diabetic state.
The mechanism of glucose induced insulin secretion
and other insulinotropic augmenters acting along with
glucose, bring about ATP mediated closure of mem-
brane K
+ channels and consequent depolarization lead-
ing to opening of Ca
++ channels and intra-cellular
elevation in Ca
++ that mediate insulin secretory vesicle
exocytosis. Most of the insulinotropic agents or poten-
tiators function in a back ground of glucose stimulated
permissive environment and stimulate adenylate cyclase
mediated cAMP production and PLC-b mediated forma-
tion IP3 and DAG resulting in intracellular Ca
++ signal-
ling that culminate in PKA and PKC activation, which
could in turn phosphorylate and again activate KATP
channels. Elevation of these second messengers can also
enhance insulin gene transcription [27,28]. Even other
pathways of insulin release independent of exocytosis,
by altered membrane permeability stand reported
[29,30]. Presently, the FRF fraction elevated the intra
islet levels of both cAMP and Ca
++ in a dose dependent
manner in presence of stimulating concentration of glu-
cose. The dose-dependent increase in cAMP is mani-
fested even in presence of IBMX, the PDE inhibitor. All
t h et h r e ed o s e so fF R Fe q u a l l yi n c r e a s eC a
++ level in
presence of IBMX. It would appear from the present
observations that, our FRF has potent ability to function
as a potentiating insulinotropic agent for stimulating
cAMP and Ca
++ mediated insulin secretion under the
permissive influence of glucose. It is likely that, FRF
may also mediate its insulin secretogogue function
through GLP-1 action as, flavonoids are known to
increase GLP-1 level as well as inhibit dipeptidyl pepti-
dase IV (DPP-IV), the enzyme that metabolizes GLP-1,
both of which can efficiently up regulate insulin secre-
tion from pancreatic islets in presence of glucose
[31,32].
Exposure of islets to STZ shows significantly increased
formation of peroxynitrite, NO and ROS with markedly
elevated LPO and reduced cell viability. Islets exposed
to STZ also show significantly increased mitochondrial
membrane potential. Apparently, STZ causes severe oxi-
dative and cytotoxic stress to islets that is likely to com-
promise their insulin releasing capacity. Presence of FRF
in the medium along with STZ has depicted a dose
dependent reversal of all the cytotoxic manifestations,
with the highest dose of 250 μg/mL normalizing most of
the measured parameters except for peroxynitrite and
NO formation and total cell viability. This suggests the
need for a probably higher dose to completely nullify
the NO and peroxynitrite generation potential of STZ.
The herein observed anti-oxidant, anti-ROS and NOs
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Page 11 of 13generation potentials and, maintenance of mitochondrial
membrane potential find substantial support from the
reported anti-oxidant potential of flavonoids [33-35].
Validation of observed in vitro effects of FRF in multi-
dose STZ mice has provided strong supportive evidence
as, FRF has shown a dose-dependent decrease in blood
glucose level and increase in plasma insulin titer. Cyto-
protective effect of FRF is also well evidenced by the
histological appearance of islets from STZ+FRF mice
compared to STZ mice. Further proof for the cytopro-
tective effect of FRF is provided by its anti-apoptotic
potential as seen from the TUNEL assay and the notice-
able insulin immunoreactivity. Many medicinal plants
have been shown to have significant antidiabetic effects
suggesting the presence of active phytochemicals
[36-39].
Conclusions
Overall, the present investigation has shown the pre-
sence of active phytochemicals in the methanolic extract
of OI and a rich mix of flavonoids. Hence, the present
study indicates the therapeutic potential of flavonoid
rich fraction to have significant insulin secretogogue,
insulinomimetic and cytoprotective effects. We recently
demonstrated the role of Oreocnide flavonoids in pan-
creatic beta cell regeneration mouse model [40]. Further,
clinical trials are necessary to assess the therapeutic
potential of flavonoid rich fraction to counteract the
manifestations of diabetes mellitus.
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